* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, September 15, 2025
Earth-News
  • Home
  • Business
  • Entertainment

    From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

    Fall’s Hottest Ski Films Are Going on Tour—Here’s the List – yahoo.com

    Experience the Thrill: Fall’s Hottest Ski Films Hit the Road-Don’t Miss the Tour!

    Ryan Reynolds reveals he called a journalist who said mean things about John Candy – yahoo.com

    Ryan Reynolds Reveals the Moment He Stood Up to a Journalist Who Insulted John Candy

    Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

    Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

    Behind the turntables: DJ Johnny Kage’s story of perseverance – yahoo.com

    Behind the Turntables: DJ Johnny Kage’s Inspiring Journey of Perseverance

    The other WWE star James Gunn wanted for Peacemaker instead of John Cena – yahoo.com

    The WWE Star James Gunn Originally Wanted for Peacemaker Instead of John Cena

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

    Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable – The Guardian

    Billion-Dollar Coffins? How New Technology Could Make Oceans Transparent and Expose Submarines

    What if artificial intelligence is just a “normal” technology? – The Economist

    What if artificial intelligence is just a “normal” technology? – The Economist

    Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

    Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

    Aston Martin to integrate Pirelli’s cyber tyre technology in future models – Just Auto

    Aston Martin to Revolutionize Future Models with Pirelli’s Cutting-Edge Cyber Tyre Technology

    Figure Technology’s stock sizzles after IPO, as investors stay hungry for crypto deals – MarketWatch

    Figure Technology’s Stock Skyrockets After IPO Amid Surging Crypto Investor Excitement

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment

    From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

    Fall’s Hottest Ski Films Are Going on Tour—Here’s the List – yahoo.com

    Experience the Thrill: Fall’s Hottest Ski Films Hit the Road-Don’t Miss the Tour!

    Ryan Reynolds reveals he called a journalist who said mean things about John Candy – yahoo.com

    Ryan Reynolds Reveals the Moment He Stood Up to a Journalist Who Insulted John Candy

    Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

    Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

    Behind the turntables: DJ Johnny Kage’s story of perseverance – yahoo.com

    Behind the Turntables: DJ Johnny Kage’s Inspiring Journey of Perseverance

    The other WWE star James Gunn wanted for Peacemaker instead of John Cena – yahoo.com

    The WWE Star James Gunn Originally Wanted for Peacemaker Instead of John Cena

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

    Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable – The Guardian

    Billion-Dollar Coffins? How New Technology Could Make Oceans Transparent and Expose Submarines

    What if artificial intelligence is just a “normal” technology? – The Economist

    What if artificial intelligence is just a “normal” technology? – The Economist

    Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

    Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

    Aston Martin to integrate Pirelli’s cyber tyre technology in future models – Just Auto

    Aston Martin to Revolutionize Future Models with Pirelli’s Cutting-Edge Cyber Tyre Technology

    Figure Technology’s stock sizzles after IPO, as investors stay hungry for crypto deals – MarketWatch

    Figure Technology’s Stock Skyrockets After IPO Amid Surging Crypto Investor Excitement

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home General

SELECT: Semaglutide Reduces CV Events and Diabetes Risk

June 24, 2024
in General
SELECT: Semaglutide Reduces CV Events and Diabetes Risk
Share on FacebookShare on Twitter

ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73% in people with established cardiovascular disease and obesity compared with placebo, regardless of baseline A1c levels, according to two new analyses of the SELECT trial.

In the first of the two studies, presented at the American Diabetes Association (ADA) 84th Scientific Sessions and published online in the journal Diabetes Care, researchers looked at the effect of semaglutide on the progression of glycemia in people with cardiovascular issues and overweight or obesity, who did not have diabetes.

Among those who took semaglutide, a smaller number with pre-diabetes at baseline progressed to diabetes, and a greater proportion regressed to normal A1c levels than those taking placebo, said lead author Steven E. Kahn, MBChB, professor of medicine at the University of Washington in Seattle. 

Overall, “semaglutide improved glycemic control in people at high risk of cardiovascular disease,” he told ADA attendees.

However, despite the increase in regression to normal glycemic levels, semaglutide did not slow glycemic progression over time, he reported. 

The original SELECT trial evaluated the effect of semaglutide on patients with overweight or obesity and atherosclerotic cardiovascular disease on major adverse cardiovascular events (MACE). As previously reported by Medscape Medical News, the anti-obesity drug reduced MACE by around 20% vs placebo in this high-risk population. 

In this prespecified secondary analysis of the SELECT trial, Kahn and colleagues looked at glycemia through 156 weeks (3 years) of once-weekly treatment with either semaglutide (n=8803) or placebo (n=8801). 

At baseline, 33.5% of all participants had a normal glycemic level, defined as A1c of less than 5.7%. About two thirds had pre-diabetes (A1c of 5.7% to

At three years, 69.5% of study participants taking semaglutide had a normal glycemic level, compared with 35.8% of those taking placebo (P <.0001 among those with a normal a1c level at baseline of participants receiving semaglutide developed diabetes placebo recipients for in the intermediate glycemia group taking compared placebo. highest-level glycemic>

After 20 weeks, the A1c levels increased similarly in the placebo and semaglutide arms, but those taking semaglutide had smaller increases.

The rate of glycemic deterioration was greatest in those who started with the highest A1c levels at baseline, “an observation likely due to less residual beta-cell function in this group,” write the authors.

In an accompanying editorial in Diabetes Care, Shivani Misra, MD, PhD, from Imperial College London, UK, said, “There was a clear effect of semaglutide to lower glycemia, but importantly A1c increased over time at a similar rate in both semaglutide and placebo arms, indicating a clear progressive loss of beta-cell function.”

Kahn noted that SELECT researchers did not measure insulin sensitivity or beta-cell function.

CV Risk Reduction for All A1c Levels

In a separate study, Ildiko Lingvay, MD, MPH, MSCS, professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center in Dallas, and colleagues showed that semaglutide’s ability to reduce cardiovascular events seen in the primary results from SELECT held up even for those who had normal A1c levels at baseline.

The new analysis first looked at MACE, its individual components, expanded MACE (cardiovascular mortality, nonfatal myocardial infarction, or stroke; coronary revascularization; or hospitalization for unstable angina), a heart failure composite (heart failure hospitalization or urgent medical visit or cardiovascular mortality), coronary revascularization, and all-cause mortality by baseline A1c subgroup and categories of A1c change.

The researchers found the reduction in these events was similar to the initial results of the SELECT trial and independent of baseline A1c. 

Cardiovascular outcomes were “also consistent across subgroups of A1c change,” they reported.

The analysis shows that “these beneficial effects of semaglutide will be anticipated across the glycemic continuum,” said Lingvay at the ADA meeting. 

“Even if a patient has a completely normal A1c they would still benefit from semaglutide for cardiovascular risk reduction,” she said. “And even if there’s no improvement in A1c, we will still see the benefits.”

Caution Warranted?

The positive results of these analyses may encourage greater use of semaglutide, which was approved by the US Food and Drug Administration for cardiovascular risk reduction earlier this year. 

Following the approval, the Centers for Medicare & Medicaid Services told health plans that it would cover 2.4 mg semaglutide injection for overweight or obese individuals with preexisting cardiovascular disease, reversing some 40 years of noncoverage of weight loss drugs. 

Commenting at the meeting, editorialist Misra said, “I’m very excited by all of these new agents, but I believe some caution is also needed.” 

Although, as she noted in her editorial, the role of GLP-1 receptor agonists is quickly expanding to include cardiovascular risk management, and perhaps prevention of type-2 diabetes, many questions remain, she said. 

She called for a mediation analysis to account for changes in body weight, cholesterol, blood pressure, C-reactive protein, and renal function, in part to fully understand the effects of semaglutide.

“Another elephant in the room is that we need to equitably deploy these agents,” said Misra, speaking at ADA. 

Four out of five people with type 2 diabetes reside in low- and middle-income countries, she noted. “If we really want to get these agents to the right people, we need to develop stratification approaches to identify those most likely to benefit and approaches that will be cost-effective for the global population.”

Misra is also interested in how the drugs will be used in younger adults with type 2 diabetes who are increasingly at risk for later cardiovascular consequences.

SELECT and the two new trials are sponsored by Novo Nordisk, the company that markets semaglutide (Wegovy). All authors received some compensation from Novo Nordisk during SELECT, and all authors reported lengthy disclosures. Kahn reports advisory board/consulting fees from AltPep, Bayer, Boehringer Ingelheim, Casma Therapeutics, Eli Lilly, Intarcia, Merck, Novo Nordisk, Oramed Pharmaceuticals, Pfizer, and Third Rock Ventures. He is also editor-in-chief of Diabetes Care but was not involved in any decisions regarding review of either manuscript or acceptance. 

Lingvay received advisory and consulting fees or other support from Altimmune, AstraZeneca, Bayer, Biomea Fusion, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen, MannKind, Mediflix, Merck, Metsera, Novo Nordisk, PharmaVentures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD, and Zealand Pharma. 

Misra has received speaker fees from Sanofi and Lilly for scientific talks over which she had complete control, has a personal award from the Wellcome Trust, and is supported by the Imperial Biomedical Research Centre. 

Alicia Ault is a Saint Petersburg, Florida-based freelance journalist whose work has appeared in publications including JAMA and Smithsonian.com. You can find her on X (formerly Twitter) @aliciaault. 

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/select-semaglutide-reduces-cv-events-and-diabetes-risk-2024a1000bma

Previous Post

Delaying Statin Therapy in Diabetes Increases CV Risk

Next Post

Trial: Fenofibrate Slows Diabetic Retinopathy Progression

Underdogs Czechia take out Serbia in straight sets at Men’s Volleyball World Championship – Volleyball World

Underdogs Czechia take out Serbia in straight sets at Men’s Volleyball World Championship – Volleyball World

September 15, 2025
The Market Isn’t Lagging – It’s Distorted: Why Investors Must Stop Treating the S&P as the Economy’s Crystal Ball – MSN

The Market Isn’t Lagging – It’s Distorted: Why Investors Must Stop Treating the S&P as the Economy’s Crystal Ball – MSN

September 15, 2025

From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

September 15, 2025
A multibillion-dollar oil project is impacting locals’ health and livelihood in Uganda – NPR

Multibillion-Dollar Oil Project Threatens Health and Livelihoods of Ugandan Communities

September 15, 2025
Politics chat: Assassination of Charlie Kirk and the rise of political violence – NPR

The Alarming Rise in Political Violence and the Threat Facing Charlie Kirk

September 15, 2025
Washington takes on flawed federal climate report – NewsRadio 560 KPQ

Washington Challenges Key Flaws in Federal Climate Report

September 14, 2025
James Webb telescope’s ‘starlit mountaintop’ could be the observatory’s best image yet — Space photo of the week – Live Science

James Webb Telescope Unveils Stunning ‘Starlit Mountaintop’ – Perhaps Its Most Breathtaking Image Yet

September 14, 2025

Colby College Announces Exciting New $150 Million Science Facility Funded by Anonymous Donor

September 14, 2025
Maine Coon Cat’s Sweet Love Story With Tiny Sphynx Kitty Is Touching Hearts – yahoo.com

Adorable Maine Coon and Tiny Sphynx Share a Heartwarming Love Story

September 14, 2025

Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

September 14, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (820)
  • Economy (840)
  • Entertainment (21,718)
  • General (17,042)
  • Health (9,884)
  • Lifestyle (855)
  • News (22,149)
  • People (843)
  • Politics (849)
  • Science (16,050)
  • Sports (21,340)
  • Technology (15,822)
  • World (823)

Recent News

Underdogs Czechia take out Serbia in straight sets at Men’s Volleyball World Championship – Volleyball World

Underdogs Czechia take out Serbia in straight sets at Men’s Volleyball World Championship – Volleyball World

September 15, 2025
The Market Isn’t Lagging – It’s Distorted: Why Investors Must Stop Treating the S&P as the Economy’s Crystal Ball – MSN

The Market Isn’t Lagging – It’s Distorted: Why Investors Must Stop Treating the S&P as the Economy’s Crystal Ball – MSN

September 15, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version